Finanzwire Finanzwire
Basculer en Français
10091 Companies
206522 Keywords
136692 Articles
109465 Press releases
Headlines Articles Press releases ONXEO Remove
  1. Home
  2. Companies
  3. ONXEO
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 05/22/2024 at 20:51, 1 year 10 months ago

    Valerio Therapeutics Advances VIO-01 Clinical Trial with Positive Results

    Drug Development Solid Tumors Clinical Trial Valerio Therapeutics VIO-01
  • PRESS RELEASE

    published on 05/22/2024 at 20:46, 1 year 10 months ago

    Inside Information / Other news releases

    Valerio Therapeutics completes dosing for first cohort of subjects in Phase 1/2 VIO-01 trial for solid tumors, showing encouraging tolerability. Phase 1b aims to determine recommended dose in selected solid tumors
    Solid Tumors Valerio Therapeutics VIO-01 Trial Phase 1/2 DNA Damage Response
    Logo of ONXEO
  • BRIEF

    published on 04/30/2024 at 23:19, 1 year 10 months ago

    Valerio Therapeutics Reports 2023 Fiscal Year Results and Clinical Updates

    Biotechnology Clinical Trials Financial Results 2023 Valerio Therapeutics VIO-01
  • PRESS RELEASE

    published on 04/30/2024 at 23:14, 1 year 10 months ago

    Annual financial and audit reports / Terms of availability of the annual financial report

    Valerio Therapeutics reports full year 2023 financial results and provides clinical development updates. The company's cash position is €6.8 million as of December 31, 2023, ensuring financial visibility until Q4 2024
    Financial Results Cash Position 2023 Clinical Development Valerio Therapeutics
    Logo of ONXEO
Previous page
1 2 3
Accesswire
  • Published on 03/26/2026 at 04:55, 1 hour 33 minutes ago

    Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives

  • Published on 03/26/2026 at 00:40, 5 hours 48 minutes ago

    Challenger RC Resource Upgrade Drilling Complete

  • Published on 03/26/2026 at 00:30, 5 hours 58 minutes ago

    Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results

  • Published on 03/25/2026 at 19:15, 11 hours 13 minutes ago

    Gemina Laboratories Ltd. Announces Delisting from the CSE

  • Published on 03/25/2026 at 13:30, 16 hours 58 minutes ago

    Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada

View all ACCESSWIRE
EQS Group
  • Published on 03/26/2026 at 06:06, 21 minutes ago

    Bajaj Mobility AG Annual Financial Report 2025: Successful Turnaround Following an Intensive Year of Restructuring – Operational Stabilization and Record Motorsport Season

  • Published on 03/26/2026 at 06:00, 27 minutes ago

    Bajaj Mobility AG confirms revenue and earnings for 2025 and publishes the annual report 2025

  • Published on 03/26/2026 at 04:45, 1 hour 42 minutes ago

    Powering global maritime decarbonization, Shanghai Electric delivers first large-scale biomethanol bunkering for international shipping

  • Published on 03/26/2026 at 01:05, 5 hours 22 minutes ago

    Blokees Announces Upgrade Brand Mission at 2026 Global Partner Conference

  • Published on 03/25/2026 at 20:00, 10 hours 27 minutes ago

    Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press

View all EQS
Les Echos
  • Published on 03/25/2026 at 18:53, 11 hours 34 minutes ago

    LNA SANTE : 2025 Annual Results

  • Published on 03/25/2026 at 18:31, 11 hours 56 minutes ago

    Strong investment performance and active roll-out of our strategy

  • Published on 03/25/2026 at 17:45, 12 hours 43 minutes ago

    Combined General Meeting on May 05, 2026: publication of the notice of Meeting

  • Published on 03/25/2026 at 17:45, 12 hours 43 minutes ago

    GUILLEMOT CORPORATION: 2025 ANNUAL RESULTS

  • Published on 03/25/2026 at 17:42, 12 hours 46 minutes ago

    2025/2026 Second quarter Sales

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy